Our goal is to identify Corporate Supporters that share our mission to find a cure for Niemann-Pick Type C disease through outreach, education, and philanthropy. If you are interested in becoming a Corporate Supporter, please contact Sean Kassen at email@example.com.
Mallinckrodt Pharmaceuticals is a pharmaceutical company focused on their mission: Managing Complexity. Improving Lives. They provide medicines to address unmet patient needs, stemming from 150 years of using our unique strengths, experience and expertise to help improve people’s lives. They are currently developing VTS-270, a potential treatment for NPC disease.